Prism Biotech

Prism Biotech

Prelaunch prescriber profiling and targeting

Overview

Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.

About Prism Biotech

Simplify's Rating
Why Prism Biotech is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Merion Township, Pennsylvania

Founded

2019

Get referred to Prism Biotech

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ono paid an initial milestone in November 2025, proving partner monetization.
  • Receptor.AI partnership on March 12, 2026 expands PRISM into AI-guided discovery.
  • Eisai presented E7386 preclinical and Phase 1 results in 2026, strengthening credibility.

What critics are saying

  • Servier terminated its collaboration and licensing agreement with PRISM BioLab in 2026.
  • Boehringer Ingelheim agreement expired in 2026, shrinking partnered revenue optionality.
  • PRISM depends on external partnerships; a pipeline failure would crush Japan-listed growth equity valuation.

What makes Prism Biotech unique

  • PepMetics® targets intracellular PPIs and membrane proteins using orally available small molecules.
  • Eisai and PRISM co-created E7386, validating PRISM’s chemistry in oncology.
  • PRISM licenses platform discovery across pharma partners, not just single in-house programs.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Prism Biotech is Hiring for 208 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →